Senior Director, Oncology Clinical Educators
Required skills
- Oncology
- Market Access
- Payer Account Management
- National Health Plans
- Regional Health Plans
- PBMs
- Medicare
- Medicaid
- VA/DoD
- Formulary
Nice to have
- Healthcare industry trends
- Payer policies
- Competitive activity
- IDNs
Role summary
Summit Therapeutics is seeking a Senior Director, Oncology Clinical Educators to lead and manage select national and sub-national payers and assigned accounts. This customer-facing role is crucial for ensuring broad access, reimbursement, and patient affordability for oncology drug candidates and approved products. The Director will build and maintain strong relationships with key decision-makers within health plans, PBMs, Medicare, Medicaid, and other entities, influencing coverage and reimbursement decisions. Responsibilities include executing brand access strategies, developing account-specific plans, collaborating with internal teams (Medical Affairs, Patient Services, Sales), and providing strategic insights to inform product launches and market access strategies, all while ensuring compliance with industry regulations.
About Summit:
Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.
Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:
Non-small Cell Lung Cancer (NSCLC)
HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.
Colorectal Cancer (CRC)
HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.
Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.
Overview of Role:
The Senior Director, Oncology Clinical Educators will establish and lead Summit Therapeutics’ field based Clinical Educator function, developing the strategy, infrastructure, and capabilities to support the launch and commercialization of the Company’s oncology portfolio, beginning with its NSCLC bispecific antibody. This leader will oversee the delivery of compliant, on-label education to healthcare professionals to support clinical readiness and appropriate treatment implementation.
This leader will lead the national education strategy, establish territory coverage and priorities, and partner cross-functionally while maintaining appropriate compliance oversight. The role is not a sales or marketing role, its educational objectives, performance measures, and incentives will remain independent of sales and marketing performance.
Role and Responsibilities:
Experience, Education and Specialized Knowledge and Skills:
This is the pay for this position
Pay Transparency$203,000—$253,000 USDActual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.
Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.
Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.
Similar roles
- Executive Oncology Account Manager (North Phoenix)Summit Therapeutics, Inc. · North Phoenix, AZ · Onsite
- Executive Oncology Account Manager (Las Vegas)Summit Therapeutics, Inc. · Las Vegas, NV · Onsite
- Executive Oncology Account Manager (White Plains)Summit Therapeutics, Inc. · White Plains, NY · Onsite
